Morgan Stanley Says These 3 Reliable Dividend Stocks Should Be on Your Buy List (Especially Right Now)

S&P 500

3,871.70

+15.77(+0.41%)

 

Dow 30

30,764.28

+58.05(+0.19%)

 

Nasdaq

11,497.85

+72.80(+0.64%)

 

Russell 2000

1,806.93

+19.42(+1.09%)

 

Crude Oil

83.91

-0.03(-0.04%)

 

Gold

1,694.80

+23.70(+1.42%)

 

Silver

19.92

+0.74(+3.87%)

 

EUR/USD

0.9894

-0.0078(-0.78%)

 

10-Yr Bond

3.5100

-0.0610(-1.71%)

 

GBP/USD

1.1335

-0.0045(-0.40%)

 

USD/JPY

143.5640

-0.1390(-0.10%)

 

BTC-USD

19,376.88

+372.17(+1.96%)

 

CMC Crypto 200

446.29

+8.41(+1.92%)

 

FTSE 100

7,237.64

+44.98(+0.63%)

 

Nikkei 225

27,313.13

-375.29(-1.36%)

 

The major investment bank Morgan Stanley has been sounding alerts about the increasingly difficult economic conditions for several months now, and the firm’s chief US equity strategist Mike Wilson headed up a recent note on the topic of defensive investing, especially dividend investing.

Wilson lays out a clear strategy for dividend investors, starting with the fact that the best dividend stocks, by their nature, provide an income stream that is both secure and stable, and will provide protection for investors in any market environment.

“We believe the ‘dividend sweet spot’ is not to find the highest yielding stock,” Wilson says, “but to find consistent companies who can grow their dividend year-over-year and have a proven track record. It’s this underlying stability combined with the dividend return that can provide a defensive cushion during periods of market turbulence – similar to today’s environment.”

Against this backdrop, the analysts at Morgan Stanley have picked out stocks that offer investors some of the most reliable dividends available. Using the TiipRanks platform, we’ve pulled up the details on three of those picks. Let’s dive in.

Philip Morris International Inc. (PM)

The first stock we’ll look at, Philip Morris, is well-known as one of the world’s largest tobacco companies, and the owner of venerable Marlboro brand cigarettes. While cigarettes and other smoking products make up the lion’s share of the firm’s sales, PM is strongly emphasizing its smokeless product lines. These include vapes, heated tobacco products, and oral nicotine pouches. The company boasts that its smokeless products, especially the heated tobacco lines, have helped over 13 million adult smokers worldwide quit smoking.

The company’s dividend is worth a close look, as it offers investors a reliable payment with a long-term history of steady growth. PM first started paying out the dividend in 2008, when it went public; since then, the company has not missed a quarterly payment – and has raised the dividend every year, with a CAGR of 7.5%. The current quarterly dividend payment is $1.27 per share, up 2 cents from the previous quarter. The dividend annualizes to $5.08 per common share, and yields a strong 5.3%. The newly raised dividend is scheduled for payment on September 27.

The dividend payment is supported, and fully covered, by PM’s regular quarter earnings, which in 2Q22 came in at $1.32 per diluted share. Philip Morris is targeting full-year diluted EPS in the range of $5.73 to $5.88, which is good news for dividend investors, as achieving that target will keep the dividend easily affordable for the company.

Analyst Pamela Kaufman, covering this tobacconist for Morgan Stanley, takes notice of the company’s increasing sales in smokeless products, as well as its generally sound financial position, in recommending the stock.

“Q2 results reflect many of the key tenets of our thesis, including attractive IQOS momentum with accelerating new IQOS user growth, solid combustibles fundamentals with positive international cigarette market share/volumes, and increased underlying guidance,” Kaufman opined.

Looking forward, Kaufman rates PM an Overweight (i.e. Buy), and sets a $112 price target for ~16% upside potential. (To watch Kaufman’s track record, click here)

Overall, Philip Morris shares have a Moderate Buy from the Street consensus, based on 7 reviews that include 4 Buys and 3 Holds. (See PM stock forecast on TipRanks)

Citizens Financial Group, Inc. (CFG)

Next up is Citizens Financial Group, a retail banking firm in the US markets. Citizens Financial is based in Rhode Island, and operates through 1,200 branches in 14 states, centered in New England but extending to the Mid-Atlantic and Midwest regions. Retail and commercial customers can access a full range of services, including checking and deposit accounts, personal and small business loans, wealth management, even foreign exchange. For customers unable to reach a branch office, CFG offers mobile and online banking, and more than 3,300 ATM machines.

Citizens Financial saw revenues exceed $2.1 billion in 2Q22, a year-over-year jump of 23.5%. Earnings came in below expectations; at $364 million, net income was down 43% y/y, and EPS, at 67 cents, was less than half of the $1.44 reported in the year-ago quarter.

Despite the drop in earnings and share value, Citizens Financial felt confident enough to expand its capital return program. The Board authorized, in July, share repurchases up to $1 billion, and increase of $250 million from the previous authorization.

At the same time, the company also announce an 8% increase in its quarterly common share dividend payment. The new payment, of 42 cents per share, went out in August; it annualizes to $1.68 and gives a yield of 4.5%. Citizens Financial has a history of both reliable dividend payments and regular increases going back to 2014; the dividend has been raised twice in the last three years.

This stock has caught the eye of Morgan Stanley’s Betsy Graseck, who lays out an upbeat case for buying into CFG.

“We are Overweight Citizens due to its above-peer earnings growth driven by multiple broad-based drivers, including its differentiated loan categories which drive better-than-peer loan growth, disciplined expense management, and EPS upside from bolt-on fee based acquisitions,” Graseck wrote.

Graseck’s Overweight (i.e. Buy) rating comes with a $51 price target. Should her thesis play out, a twelve-month gain of ~37% could potentially be in the cards. (To watch Graseck’s track record, click here)

Financially sound banking firms are sure to pick up Wall Street interest, and CFG shares have 13 recent analyst reviews on file, including 10 to Buy and 3 to Hold, giving the stock a Strong Buy consensus rating. The average price target of $46.85 implies ~28% one-year gain from the trading price of $36.76. (See CFG stock forecast on TipRanks)

AvalonBay (AVB)

The third Morgan Stanley pick we’re looking at is AvalonBay, a real estate investment trust (REIT) focused on apartment properties. REIT’s have a strong reputation for paying out solid dividends; they are required by tax codes to return a certain percentage of profits directly to shareholders, and frequently use dividends to comply with the regulatory demands. AvalonBay owns, acquires, develops, and manages multi-family developments in the New York/New Jersey metropolitan area, in New England and the Mid-Atlantic regions, in the Pacific Northwest, and in California. The company targets properties in leading urban centers of its operating areas.

Rising rents have been a large component of the general increase in the rate of inflation, and that has been reflected in AvalonBay’s top line. The company’s Q2 revenue, of $650 million, was the highest in the past two years. On earnings, a ‘noisier’ metric, AvalonBay reported $138.7 million in net income attributable to stockholders; diluted EPS came in at 99 cents per share, down from $3.21 in the year-ago quarter.

While earnings per share were down, the company did report a year-over-year gain in a key metric, fund from operations (FFO) attributable to common stockholders. On a diluted basis, the FFO grew 22% y/y, from $1.97 to $2.41. This should be noted by dividend investors, as FFO is commonly used by REITs to cover the dividend.

AvalonBay’s dividend was last paid out in July, at $1.59 per common share. The next payment, for October, has already been declared at the same rate. The $1.59 quarterly payment annualizes to $6.36 per common share, and gives a yield of 3.3%. AvalonBay has paid out a quarterly dividend in every quarter – without missing a beat – since it went public in 1994, and over the past 28 years has average a 5% annual increase in the payment.

Morgan Stanley analyst Adam Kramer sees a path forward for this company, and explains why investors should get in now: “We think AVB can trade at a premium to [peers] in our coverage given peer-leading SS-Revenue and strong FFO per share growth and a differentiated development program. We believe investors have a ‘free option’ on the development pipeline as the current stock price implies a ~19.7x multiple on our ’23e FFO ex. external growth.”

Kramer uses these comments to support his Overweight (i.e. Buy) rating on the stock, and his price target, set at $242, suggests that AVB has a 26% upside potential ahead of it. (To watch Kramer’s track record, click here)

All in all, AVB shares have 8 Buys and 11 Holds, making the analyst consensus rating here a Moderate Buy. The stock is the most expensive on this list, at $190.87 per share, and the $226.17 average price target is indicative of ~18% upside potential for the coming months. (See AVB stock forecast on TipRanks)

To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.

Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Advertisement

Zacks

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cullen/Frost Bankers (CFR) have what it takes? Let’s find out.

TipRanks

J.P. Morgan Says Stock Market Downside Risk Is Limited; Here Are 3 Stocks to Consider

A strong bearish trend defined the markets in the first half of the year; since then, the key point has been volatility. Stocks hit a bottom back in June, when the S&P 500 dropped into the 3,600s. That has proven to be a support level in the last three months, and at least one strategist believes that the market won’t go much lower from here. JPMorgan global market strategist Marko Kolanovic is taking a guardedly optimistic view of the coming year, noting: “We believe that any downside from here

TipRanks

Pent-Up Demand Drives Lumber Prices Higher; Here Are 2 ‘Strong Buy’ Stocks That Could Benefit

Housing construction spiked unexpectedly in August, with 1.575 million new units started, well above the 1.445 million forecast. For investors, the situation can open up opportunities. Housing depends on several key commodities, such as lumber and cement. In fact, on Tuesday, lumber prices rose ~6% in the commodity markets amid increased demand. It brings up a situation in which investors can make gains on lumber stocks, and Wall Street’s analysts are taking a closer look at lumber companies. Us

Reuters

The Fed’s latest rate hike: five ways Americans may feel the pain

The Federal Reserve on Wednesday delivered its third straight 75-basis point interest rate hike in its campaign to drive borrowing costs high enough to bring down 40-year high inflation. Regular Americans have felt the sting of inflation for months, and the Fed’s effort to lower it so far have already made it harder for many consumers to buy things like a house or a car. Other shoes have yet to drop, though, such as a jump in unemployment or even a recession.

Investor’s Business Daily

Adobe Stock Today: Why This Bearish Put Spread Could Gain $550

Shares of Adobe crashed last week. Adobe stock fell 24% in huge volume following news of its acquisition of Figma for $20 billion. When such a quality company has a big drop like this, I like to use a strategy called a diagonal put spread.

Motley Fool

3 Toxic Cryptos to Avoid, Especially in a Bear Market

Market leader Bitcoin (BTC) is down over 70% from its all-time high and many other projects have seen even greater losses. Firstly, not only is the founder pseudonymous, Ryoshi also departed the project earlier this year.

SmartAsset

12 Topics Advisors Should Discuss With Clients During Market Volatility

Periods of market volatility can be distressing to clients. Savvy financial advisors know, however, that unsettling market conditions present an opportunity to touch base with clients and demonstrate value. Here are 12 topics Vanguard says advisors can discuss with clients … Continue reading → The post 12 Topics Advisors Should Discuss With Clients During Market Volatility appeared first on SmartAsset Blog.

Benzinga

Novartis, Moderna Partner Agrees To Merge With Beleaguered Sesen Bio

Sesen Bio Inc (NASDAQ: SESN) and privately held Carisma Therapeutics Inc have entered into a merger agreement to combine the companies in an all-stock transaction. The combined company will operate under the Carisma Therapeutics moniker under the “CARM symbol” and is expected to have approximately $180 million of cash and cash equivalents, including $30 million from concurrent financing by Carisma, which is expected to fund the company through 2024. Sesen Bio suffered FDA rejection for its lead

The Wall Street Journal

Citrix Debt Deal Prices With Large Losses For Banks

The sale of Citrix’s debt has been closely watched by private-equity investors, who rely on leveraged loans and have found they are more expensive and harder to obtain.

Investopedia

Best Pharmaceutical ETFs for Q4 2022

Pharmaceutical exchange-traded funds (ETFs) offer investors access to a basket of U.S.-based and foreign stocks of drug manufacturers and related companies in a single investment. These companies discover, develop, and produce medications used to cure disease, vaccinate, or alleviate symptoms of illness.

TipRanks

Seeking at Least 8% Dividend Yield? Analysts Suggest 3 Dividend Stocks to Buy

What’s going on in the markets lately? Since the start of this year, we’ve seen a prolonged bearish trend, and now a cycle of high volatility. Investors can be forgiven for feeling some confusion, or even some whiplash, in trying to follow the rapid ups and downs of recent weeks. One important fact does stand out, however. Over the past three months, since mid-June, we’ve see rallies and dips – but the markets have not seriously challenged that mid-June low point. Examining the situation from re

Bloomberg

Gold Fields Sees Investors Backing $7 Billion Yamana Deal

(Bloomberg) — Gold Fields Ltd.’s top executive said disquiet over the South African miner’s $7 billion offer to buy Canada’s Yamana Gold Inc. hasn’t resulted in an exodus among its top shareholders.Most Read from BloombergPutin Calls Up More Troops, Resumes Nuclear Threat Over UkraineHome-Flipper Opendoor Hit With Losses in Echo of Zillow CollapseTycoon’s Wild $3 Billion Gamble on ‘China’s LVMH’ Crashes‘Mute Your Phones’: Trump Special Master Hearing Descends Into ChaosFed Set to Reveal ‘Pain’

The Wall Street Journal

Stock Futures Edge Higher Ahead of Expected Fed Rate Rise

U.S. stock futures rose [as investors awaited a meeting of the Federal Reserve](https://www.wsj.com/articles/feds-third-straight-0-75-point-interest-rate-rise-is-anticipated-11663639672). Officials are expected to approve their third consecutive three-quarter point jump in interest rates, though markets are still pricing about a 15% chance of a full percentage point increase. In early trading in London: + U.S. stock futures rose with contracts tied to the _**S 500**_ inching up 0.25%. Dow Jones

College Football News

College Football Expert Picks, Predictions: Week 4

Week 4 college football expert picks and predictions highlighted by Florida at Tennessee, Wisconsin at Ohio State, and Arkansas at Texas A&M

Leave A Reply

Your email address will not be published.